A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian B. Berger, MD
Retina Research Center
Principal Investigator - David M. Brown, MD
Retina Consultants Houston
Principal Investigator - Dean Eliott, MD
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Principal InvestigatorKOL profile → - Diana V. Do, MD
Stanley M Truhlsen Eye Institute, University of Nebraska Medical Center
Principal Investigator - Eugene Lit, MD
East Bay Retina Institute
Principal Investigator - Goergios Papastergio, MD
Retina Institute of Hawaii
Principal Investigator - Gregg T. Kokame, MD
Retina Consultants of Hawaii, Pali Momi Medical Center
Principal Investigator - Henry L. Hudson, MD
Retina Centers, P.C.
Principal Investigator - Homayoun Tabandeh, MD
Retina Vitreous Associates
Principal Investigator - Larry S. Halperin, MD
Retina Group of Florida
Principal Investigator - Louis Glazer, MD
Vitreo-Retinal Associates
Principal Investigator - Michael J. Elman, MD
Elman Retina Group
Principal Investigator - Michael J. Tolentino, MD
Center for Retina Macula Disease
Principal Investigator - Prema Abraham, MD
Black Hills Regional Eye Institute
Principal Investigator - Richard B. Rosen, MD
New York Eye and Ear Infirmary
Principal Investigator - Robert Wong, MD
Austin Retina Associates
Principal Investigator - Ron P. Gallemore, MD. PhD
Retina Macula Institute
Principal Investigator - Surendar Purohit, MD
TLC Eye Care & Laser Center
Principal Investigator - Thomas A. Barnard, MD
Florida Retina Institute
Principal Investigator - Thomas A. Ciulla, MD
Midwest Eye Institute
Principal Investigator - Victor H. Gonzalez, MD
Valley Retina Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanley M Truhlsen Eye Institute
Omaha, Nebraska, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2012
- Primary completion
- 28 Feb 2014
- Completion
- 31 Oct 2014
- Last update posted
- 30 Aug 2017
- Registered enrollment
- 185
- Registry id
- NCT01565148
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.